Sandoz Targeted Over Generic Cancer Drug Fusilev
Pharmaceutical company Sandoz Inc. was hit Friday with a patent infringement suit in Nevada federal court by oncology drug specialist Spectrum Pharmaceuticals Inc. and the University of Strathclyde, a Scottish institution,...To view the full article, register now.
Already a subscriber? Click here to view full article